Solifenacin Succinate Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 5 mg ,10 mg

Reference Brands: Vesicare (USA/EU)

Category: Gastrointestinal Drugs

Solifenacin Succinate is available in Tablets and strengths such as 5 mg ,10 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Solifenacin Succinate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Solifenacin Succinate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Solifenacin, marketed under the brand name Vesicare, is an oral medication used to treat overactive bladder (OAB) and neurogenic detrusor overactivity (NDO). It helps reduce symptoms such as urinary urgency, increased frequency, and incontinence, improving patient comfort and quality of life. Vesicare belongs to the class of antimuscarinic agents, which work by selectively blocking muscarinic receptors in the bladder wall, preventing involuntary muscle contractions and allowing the bladder to store urine more effectively.

In addition to treating overactive bladder in adults, solifenacin is also used for managing neurogenic detrusor overactivity in children aged two years and older. NDO is a condition caused by neurological impairment, such as spinal cord injury or congenital disorders like spina bifida, leading to overactivity of the bladder muscle. Untreated NDO can increase bladder pressure, reduce storage capacity, and potentially harm the upper urinary tract, including the kidneys. By controlling bladder muscle overactivity, Vesicare helps prevent complications while improving bladder function and reducing unwanted urine leakage.

Solifenacin provides a convenient once-daily oral therapy with efficacy comparable to other antimuscarinics such as oxybutynin, tolterodine, and darifenacin, offering a reliable and well-tolerated option for managing bladder dysfunction.